As it can be seen throughout this review, HA-based polymeric nanocarriers are an attractive system for biomedical applications, mainly anticancer therapy due to recognition of HA by CD44, which allows active targeting towards certain tumor cells. The gene discussed is CD44; the disease is neoplasm.